44
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      mTORC2-IRF4 mediated metabolic reprograming is essential for macrophage alternative activation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Changes in metabolism can be initiated in response to signals received from other cells. An example of this is provided by macrophages that have been stimulated by IL-4 to become alternatively/M2 activated. In these cells, fatty acid oxidation is increased and this is critical for M2 activation. Compared to resting macrophages, M2 macrophages also exhibit changes in glucose metabolism that we have found are essential for activation. In other cell types, mTORC2 has been linked to enhanced glycolysis. We have found that mTORC2 operates in parallel with the IL-4Rα/Stat6 pathway to facilitate increased glycolysis during M2 activation. Our data strongly implicate PI3K and AKT signaling initiated by M-CSF as components in this pathway, and indicate that downstream induction of IRF4 expression plays a role in metabolic reprograming to support M2 activation. We show that loss of mTORC2 in macrophages suppresses tumor growth and decreases immunity to a parasitic nematode.

          Related collections

          Author and article information

          Journal
          9432918
          8591
          Immunity
          Immunity
          Immunity
          1074-7613
          1097-4180
          21 October 2016
          18 October 2016
          18 October 2017
          : 45
          : 4
          : 817-830
          Affiliations
          [1 ]Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
          [2 ]Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
          [3 ]Diabetic Cardiovascular Disease Center, Washington University School of Medicine, St. Louis, MO 63110, USA
          [4 ]Department of Parasitology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands
          [5 ]Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany
          [6 ]Faculty of Biology, University of Freiburg, D79104 Germany
          Author notes
          Correspondence and Lead Contact: Edward J. Pearce, Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg im Breisgau, Germany Tel: +49 (0) 761 5108 476, pearceed@ 123456ie-freiburg.mpg.de
          Article
          PMC5535820 PMC5535820 5535820 nihpa820492
          10.1016/j.immuni.2016.09.016
          5535820
          27760338
          6aa02019-bfa8-4e5d-8033-95a996c9e729
          History
          Categories
          Article

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content659

          Cited by301